食管腺癌和贲门腺癌手术治疗的远期效果

Surgical treatment of adenocarcinoma of esophagus and gastric cardia

  • 摘要: 目的:评估食管腺癌和贲门癌的手术治疗效果。方法:利用SPSS统计软件对手术治疗的患者进行回顾性的研究。结果:108例患者中食管腺癌22例(男∶女=3.5∶1,Ⅱ期15.4%,Ⅲ期76.9%,Ⅳ期7.7%),贲门癌86例(男∶女=4.6∶1,Ⅰ期2.9%,Ⅱ期7.1%,Ⅲ期74.3%,Ⅳ期15.7%)。30例患者获得根治性切除。食管癌中位生存期是3.75个月,贲门癌是9.36个月。根治性切除(26.1个月)显著高于姑息性切除(7.1个月,P<0.05)。姑息手术者(7.11个月)与未治疗者(11.29个月)无明显差异(P=0.353)。转移淋巴结的数目超过6个(P<0.05)或阳性率超过65.6%(P<0.01),中位生存期显著缩短。结论:手术只能显著改善根治性切除的食管和贲门腺癌患者的生存期。

     

    Abstract: Objective: To evaluate the role of surgery in the management of adenocarcinoma of esophagus and gastric cardia. Methods: The surgically treated patients with adenocarcinoma of esophagus and gastric cardia were included and retrospectively studied.Multivariate analysis of the SPSS software was used to identify the influencing factors.Results: There were twentytwo esophageal cancer (M∶F =3.5∶1,middle third 6,lower third 16) and eighty-six cancer of gastric cardia (M∶F =4.6∶1).The clinical stage of esophageal tumor were Ⅱ 15.4%,Ⅲ 76.9%,Ⅳ 7.7%;carcinoma of gastric cardia were: Ⅰ 2.9%, Ⅱ 7.1%,Ⅲ 74.3%,Ⅳ1 5.7%.Thirty patients had curative resection.The negative margin could be likely obtained if upper resection margin was grossly longer than 2.8cm and lower margin longer than 4.8cm (P<0.05).The overall median survival was 3.75 months for esophageal cancer and 9.36months for carcinoma of gastric cardia.The early staged patients had significantly better survival,64months for stage Ⅰ and Ⅱ,13.7 and 7.1months for stage Ⅲ and Ⅳ (P<0.01).Curative resection could also improve the total median survival to 26.1months in contrast with 7.1months in palliative resection (P< 0.05).When the number of lymph nodes metastases was more than 6,or the percentage of positive lymph nodes was greater than 65.6%,the median survival became significantly reduced (P=0.013,P=0.005).Conclusion: Surgery could only significantly improve the survival for early staged patients where curative resection could be achieved.

     

/

返回文章
返回